Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 57.20
-1.20 (-2.05%)
Jul 17, 2026, 5:35 PM CET
Clínica Baviera Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 17, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 916 | 796 | 499 | 375 | 285 | 346 | |
Market Cap Growth | 31.30% | 59.55% | 33.08% | 31.43% | -17.46% | 50.36% |
Enterprise Value | 936.07 | 885.63 | 569.7 | 342.95 | 357.24 | 426.82 |
Last Close Price | 57.20 | 49.70 | 31.20 | 23.00 | 17.50 | 21.20 |
PE Ratio | 21.78 | 19.26 | 12.63 | 10.41 | 9.67 | 12.62 |
Forward PE | - | 11.01 | 11.01 | 11.01 | 9.86 | 23.87 |
PEG Ratio | - | 2.65 | 2.65 | 2.65 | 2.47 | 2.19 |
PS Ratio | 3.01 | 2.64 | 1.90 | 1.67 | 1.44 | 2.00 |
PB Ratio | 8.26 | 3.64 | 2.58 | 4.12 | 2.12 | 3.17 |
P/TBV Ratio | 5.12 | 4.45 | 3.20 | 5.09 | 2.39 | 3.70 |
P/FCF Ratio | 19.57 | 17.13 | 13.86 | 10.67 | 7.24 | 9.51 |
P/OCF Ratio | 11.92 | 10.41 | 7.98 | 6.49 | 5.34 | 7.39 |
EV/Sales Ratio | 3.07 | 2.93 | 2.17 | 1.52 | 1.80 | 2.47 |
EV/EBITDA Ratio | 11.30 | 10.49 | 7.44 | 5.12 | 6.32 | 7.97 |
EV/EBIT Ratio | 15.43 | 14.63 | 10.23 | 6.86 | 8.61 | 10.83 |
EV/FCF Ratio | 19.99 | 19.06 | 15.83 | 9.76 | 9.06 | 11.75 |
Debt / Equity Ratio | 0.61 | 0.61 | 0.58 | 0 | 1.11 | 1.44 |
Debt / EBITDA Ratio | 1.12 | 1.12 | 1.04 | 0.27 | 1.95 | 2.11 |
Debt / FCF Ratio | 2.03 | 2.03 | 2.21 | 0.51 | 2.79 | 3.10 |
Net Debt / Equity Ratio | 0.40 | 0.40 | 0.36 | -0.37 | 0.53 | 0.74 |
Net Debt / EBITDA Ratio | 1.05 | 1.05 | 0.91 | -0.50 | 1.26 | 1.50 |
Net Debt / FCF Ratio | 1.91 | 1.91 | 1.92 | -0.95 | 1.80 | 2.21 |
Asset Turnover | 1.31 | 1.31 | 1.34 | 1.37 | 1.40 | 1.36 |
Inventory Turnover | 46.59 | 46.59 | 46.27 | 49.66 | 47.16 | 47.02 |
Quick Ratio | 0.09 | 0.09 | 0.21 | 1.20 | 1.03 | 1.00 |
Current Ratio | 0.97 | 0.97 | 0.95 | 1.28 | 1.09 | 1.06 |
Return on Equity (ROE) | 41.02% | 41.02% | 43.16% | 45.73% | 48.72% | 55.70% |
Return on Assets (ROA) | 18.82% | 18.82% | 20.94% | 22.51% | 21.66% | 22.23% |
Return on Invested Capital (ROIC) | 27.14% | 23.56% | 36.10% | 37.32% | 22.36% | 21.08% |
Return on Capital Employed (ROCE) | 34.86% | 34.86% | 37.79% | 41.26% | 40.09% | 42.28% |
Earnings Yield | 4.59% | 5.19% | 7.92% | 9.61% | 10.34% | 7.92% |
FCF Yield | 5.11% | 5.84% | 7.21% | 9.37% | 13.82% | 10.51% |
Dividend Yield | 2.69% | 3.32% | 5.19% | 3.62% | 6.02% | 5.02% |
Payout Ratio | 59.75% | 62.78% | 64.39% | 37.73% | 58.23% | 63.34% |
Buyback Yield / Dilution | -0.08% | -0.08% | 1.85% | 0.00% | 0.00% | -0.01% |
Total Shareholder Return | 2.61% | 3.24% | 7.04% | 3.62% | 6.02% | 5.01% |